Source comparison
Tesamorelin Dosing Protocols: Clinical Comparison
Standard HIV Lipodystrophy 2mg SC daily 26 weeks 15.2 18 +42 Gold standard. Maximal efficacy with acceptable tolerability Low-Dose Continuous 1mg SC daily 52 weeks 9.8 11 +28 Lower efficacy but improved long-term adherence in sensitive individuals High-Dose Sh
This comparison does not assign a generated winner or score.
- Standard HIV Lipodystrophy
- 2mg SC daily
- 26 weeks
- 15.2
- 18
- +42
- Gold standard. Maximal efficacy with acceptable tolerability
- Low-Dose Continuous
- 1mg SC daily
- 52 weeks
- 9.8
- 11
- +28
- Lower efficacy but improved long-term adherence in sensitive individuals
- High-Dose Short-Term
- 3mg SC daily
- 12 weeks
- 11.4
- 29
- +61
- Higher side effects without proportional benefit. Not recommended
- Intermittent Dosing (5 days on, 2 off)
- 2mg SC on dosing days
- 12.7
- 14
- +38
- Slightly reduced efficacy but may improve receptor sensitivity over time